Intrinsic Value of S&P & Nasdaq Contact Us

AbCellera Biologics Inc. ABCL NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • CA • USD

SharesGrow Score
63/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$20.17
+436.4%

AbCellera Biologics Inc. (ABCL) has 12 identified peers for comparison in the Healthcare sector. Peers include AVRO, CVAC, CWBR, HEPA, IOVA, KRYS and others.

ABCL has a market capitalization of $1.14B, compared to an average peer market cap of $3.1B. ABCL is notably smaller than its average peer.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message